和黄医药
港股通 官网
( 00013.hk)
市盈率4.99市净率1.89股息率0%上市时间2021-06-30股价20.94港币涨跌幅1.55%成交金额3,903.33万港币换手率0.21%市值182.63亿港币H股市值182.63亿港币总股本8.72亿H股本8.72亿每手股数500上市至今年化投资收益率-20.91%港股通持仓占H股比例26.97% (48.12亿港币2025-12-30) 累计做空占H股比例6.88% (12.44亿港币2025-12-24)
所属三级行业药品 (恒生) 市盈率31.63市净率3.05股息率1.07%恒生:医疗保健业药品及生物科技药品
所属指数指数纳入纳出
备注 (3): 双击编辑备注
发表讨论

和黄医药(00013) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1楊凌Non Executive Director2023-07-13--
2孫樂非Non Executive Director2022-05-162023-07-13
3MOK Shu Kam TonyIndependent Non Executive Director2017-10-01--
4JACK Graeme AllanIndependent Non Executive Director - A/F2017-03-01--
5蘇慰國Executive DirectorCEO2017-03-01--
6CARTER Rutherford PaulIndependent Non Executive Director2017-02-01--
7KAREN Jean FERRANTEIndependent Non Executive Director2017-02-012023-05-12
8ELDAR DanNon Executive Director2016-08-01--
9鄭澤鋒Executive Director2011-02-01--
10施熙德Non Executive Director2006-04-01--
11HOGG Christian LawrenceExecutive DirectorCEO2006-04-012022-03-03
12杜志強Executive DirectorChairman2000-12-01--